Voyager Therapeutics Inc (VYGR)
6.65
-0.35
(-5.00%)
USD |
NASDAQ |
Nov 04, 16:00
6.655
0.00 (0.00%)
After-Hours: 20:00
Voyager Therapeutics Enterprise Value: -8.375M for Nov. 4, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 04, 2024 | -8.375M |
| November 01, 2024 | 10.71M |
| October 31, 2024 | 1.441M |
| October 30, 2024 | 1.987M |
| October 29, 2024 | 14.53M |
| October 28, 2024 | 11.80M |
| October 25, 2024 | -2.921M |
| October 24, 2024 | -12.46M |
| October 23, 2024 | -20.37M |
| October 22, 2024 | -33.46M |
| October 21, 2024 | 46.70M |
| October 18, 2024 | 69.06M |
| October 17, 2024 | 65.79M |
| October 16, 2024 | 60.34M |
| October 15, 2024 | 2.532M |
| October 14, 2024 | 30.34M |
| October 11, 2024 | 20.53M |
| October 10, 2024 | 3.623M |
| October 09, 2024 | -2.376M |
| October 08, 2024 | 15.07M |
| October 07, 2024 | -0.7399M |
| October 04, 2024 | 12.89M |
| October 03, 2024 | -44.37M |
| October 02, 2024 | -53.64M |
| October 01, 2024 | -52.00M |
| Date | Value |
|---|---|
| September 30, 2024 | -52.00M |
| September 27, 2024 | -52.00M |
| September 26, 2024 | -49.82M |
| September 25, 2024 | -56.36M |
| September 24, 2024 | -41.64M |
| September 23, 2024 | -38.37M |
| September 20, 2024 | -30.19M |
| September 19, 2024 | -26.37M |
| September 18, 2024 | -31.28M |
| September 17, 2024 | -30.73M |
| September 16, 2024 | -31.28M |
| September 13, 2024 | -30.19M |
| September 12, 2024 | -31.82M |
| September 11, 2024 | -28.55M |
| September 10, 2024 | -31.28M |
| September 09, 2024 | -33.46M |
| September 06, 2024 | -36.73M |
| September 05, 2024 | -25.28M |
| September 04, 2024 | -32.91M |
| September 03, 2024 | -30.19M |
| August 30, 2024 | -13.28M |
| August 29, 2024 | -14.92M |
| August 28, 2024 | -17.10M |
| August 27, 2024 | -9.465M |
| August 26, 2024 | 4.168M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-56.36M
Minimum
Sep 25 2024
335.75M
Maximum
Jun 20 2023
103.86M
Average
95.59M
Median
Dec 09 2020
Enterprise Value Benchmarks
| NovaBay Pharmaceuticals Inc | 3.645M |
| Palatin Technologies Inc | 13.74M |
| iBio Inc | 9.837M |
| Theriva Biologics Inc | -12.61M |
| Oragenics Inc | 1.996M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -10.14M |
| Revenue (Quarterly) | 29.58M |
| Total Expenses (Quarterly) | 44.60M |
| EPS Diluted (Quarterly) | -0.18 |
| Profit Margin (Quarterly) | -34.29% |
| Earnings Yield | 3.31% |
| Normalized Earnings Yield | 3.308 |